FDA Drug Application (021839) for INCRELEX by IPSEN INC

Back to FDA Applications sponsored by IPSEN INC

Application Number021839
Product Number001
FormINJECTABLE;SUBCUTANEOUS
Dosage40MG/4ML (10MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameINCRELEX
Active IngredientMECASERMIN RECOMBINANT



Back to FDA Applications sponsored by IPSEN INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.